Cargando…
Extracellular vesicle contents as non-invasive biomarkers in ovarian malignancies
Ovarian cancer most commonly presents at an advanced stage where survival is approximately 30% compared with >80% if diagnosed and treated before disease spreads. Diagnostic capabilities have progressed from surgical staging via laparotomy to image-guided biopsies and immunohistochemistry stainin...
Autores principales: | McAlarnen, Lindsey A., Gupta, Prachi, Singh, Reena, Pradeep, Sunila, Chaluvally-Raghavan, Pradeep |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9420349/ https://www.ncbi.nlm.nih.gov/pubmed/36090475 http://dx.doi.org/10.1016/j.omto.2022.08.005 |
Ejemplares similares
-
Emerging Role of Extracellular Vesicles in Immune Regulation and Cancer Progression
por: Mittal, Sonam, et al.
Publicado: (2020) -
Tumor Derived Extracellular Vesicles Drive T Cell Exhaustion in Tumor Microenvironment through Sphingosine Mediated Signaling and Impacting Immunotherapy Outcomes in Ovarian Cancer
por: Gupta, Prachi, et al.
Publicado: (2022) -
B Cells as an Immune-Regulatory Signature in Ovarian Cancer
por: Gupta, Prachi, et al.
Publicado: (2019) -
Metabolic Reprogramming in Tumor-Associated Macrophages in the Ovarian Tumor Microenvironment
por: Kumar, Sudhir, et al.
Publicado: (2022) -
Patient-Derived Ovarian Cancer Spheroids Rely on PI3K-AKT Signaling Addiction for Cancer Stemness and Chemoresistance
por: Parashar, Deepak, et al.
Publicado: (2022)